Feb 1, 2023 8:09 PM
BACK TO TOP
KSE100
40,619.94
-53.12
(-0.13%)
ALLSHR
27,085.05
-15.82
(-0.06%)
KSE30
15,170.41
-20.02
(-0.13%)
KMI30
69,371.12
-68.26
(-0.10%)
BKTi
9,411.43
43.07
(0.46%)
OGTi
11,500.64
-76.75
(-0.66%)
KMIALLSHR
19,636.00
-30.39
(-0.15%)
PSXDIV20
13,892.49
44.67
(0.32%)
UPP9
11,196.27
-12.24
(-0.11%)
NITPGI
9,229.48
-19.22
(-0.21%)
NBPPGI
10,754.99
-29.52
(-0.27%)
MZNPI
8,812.59
-26.02
(-0.29%)
JSMFI
8,731.88
-42.19
(-0.48%)
ACI
6,540.86
14.74
(0.23%)
HBLTTI
10,707.97
31-01-2023
4.97
(0.05%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.23.79
-0.24
(-1.00%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Feb 1, 2023 4:12 PM
REG
FUT
ODL
Open
24.29
High
24.39
Low
23.70
Volume
277,520
CIRCUIT BREAKER
22.23 — 25.83
DAY RANGE
23.70 — 24.39
52-WEEK RANGE
20.95 — 40.20
Ask Price
0.00
Ask Volume
0
Bid Price
23.79
Bid Volume
8,005
LDCP
24.03
VAR
11.50
HAIRCUT
22.50
P/E Ratio (TTM) **
7.75
1-Year Change *
-32.51%
YTD Change *
-1.49%
Last update: Wed, Feb 1, 2023 1:08 PM
Open
24.30
High
24.50
Low
24.00
Close
24.20
Change
0.46%
LDCP
24.09
Volume
21,500
Total Trades
19
CIRCUIT BREAKER
22.28 — 25.90
DAY RANGE
24.00 — 24.50
Ask Price
24.20
Ask Volume
5,000
Bid Price
0.00
Bid Volume
0
Last update: Mon, Jan 2, 2023 8:00 AM
Open
0.00
High
0.00
Low
0.00
Close
25.93
Change
0.00%
LDCP
24.90
Volume
0
Total Trades
0
CIRCUIT BREAKER
23.03 — 26.77
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Mon, Jan 30, 2023 8:00 AM
Open
0.00
High
0.00
Low
0.00
Close
23.56
Change
0.00%
LDCP
25.31
Volume
0
Total Trades
0
CIRCUIT BREAKER
23.41 — 27.21
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Open
32.52
High
32.99
Low
32.30
Close
32.49
Change
0.99%
LDCP
0.00
Volume
1,708
Total Trades
29
CIRCUIT BREAKER
21.63 — 26.43
DAY RANGE
32.30 — 32.99
Ask Price
32.79
Ask Volume
27
Bid Price
32.49
Bid Volume
399
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Mr. Rizwan AhmadCEO
Mr. Nadeem AmjadChairman
Mr. Muhammad RiazCompany Secretary
ADDRESS

Corporate Office: 588-Q Block, Johar Town, Lahore

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
5,435,091.95
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 31, 2022Transmission of Quarterly Report for the Period Ended September 30, 2022 View   PDF
Oct 28, 2022Financial Results for the Quarter ended September 30, 2022 View   PDF
Oct 7, 2022Transmission of Annual Report for the year ended June 30, 2022 View   PDF
Sep 23, 2022Financial Results for the year ended June 30, 2022 View   PDF
Apr 28, 2022Transmission of Quarterly Report for the Period Ended March 31, 2022 View   PDF
Apr 20, 2022Financial Results for the 3rd Quarter ended March 31, 2022 View   PDF
Feb 28, 2022Transmission of 2nd Quarter Report for the Period ended December 31, 2021 View   PDF
Feb 22, 2022Financial Results for the 2nd Quarter ended December 31, 2021 View   PDF
Oct 29, 2021Financial Results for the first quarter ended September 30, 2021 View   PDF
Oct 7, 2021Transmission of Annual Report for the year ended June 30, 2021 View   PDF
DateTitleDocument
Nov 11, 2022Resolutions adopted in Annual General Meeting View   PDF
Oct 21, 2022Board Meeting View   
Oct 7, 2022Notice of Annual General Meeting View   PDF
Sep 16, 2022Board Meeting View   
Apr 12, 2022Board Meeting View   
Feb 11, 2022Board Meeting View   
Dec 29, 2021Resolutions Passed in Annual General Meeting View   PDF
Oct 22, 2021Board Meeting View   
Oct 7, 2021Notice of Annual General Meeting View   PDF
Sep 23, 2021Board Meeting View   
DateTitleDocument
Jan 2, 2023Corporate Briefing Session View   PDF
Oct 28, 2022Appointment of Chairman & CEO View   PDF
Oct 28, 2022Change of Management View   PDF
Oct 21, 2022Notice of Election of Directors under section 159(4) of Companies Act, 2017 View   PDF
Feb 22, 2022Material Information View   PDF
Feb 18, 2022Material Information View   PDF
Dec 31, 2021Material Information View   
Nov 25, 2021Credit of Final Cash Dividend View   
Nov 22, 2021Material Information View   
Nov 18, 2021Credit of Bonus Share Certificates View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2022202120202019
Sales9,779,8805,795,4043,527,6252,607,028
Profit after Taxation635,884351,768143,41627,804
EPS2.803.6431.876.18
Q1 2023Q3 2022Q2 2022Q1 2022
Sales3,118,0742,748,1392,850,2791,990,953
Profit after Taxation145,809207,449261,69881,357
EPS0.640.921.110.37
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2022202120202019
Gross Profit Margin (%)13.8313.4712.3912.69
Net Profit Margin (%)6.506.074.071.07
EPS Growth (%)(23.08)(88.58)415.70(76.20)
PEG(0.51)(0.11)

Payouts

DateFinancial ResultsDetailsBook Closure
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports